JAMA Oncology

Papers
(The H4-Index of JAMA Oncology is 74. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Insights Into Immune-Mediated Disease and Cancer Risk—Delivering on the Promise of UK Biobank Big Data1331
What Is the Optimal Treatment for Vulnerable Older Women With Ovarian Cancer?486
Malignant Pericardial Effusion, or Fluid Around the Heart Due to Cancer472
Information Blocking and Oncology369
Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials—Reply326
JAMA Oncology272
Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma—Is This the New Standard of Care?270
Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring TP53 Germline Variants262
Concerns Regarding the Utility of High-Risk Pancreatic Cancer Surveillance—Reply261
Sexual Rehabilitation Needs of Gay and Bisexual Men With Cancer249
Active Cellular Immunotherapy in the Desert of Advanced Prostate Cancer237
Overall Survival in the CAIRO5 Clinical Trial233
Stargazers222
Biomarker Analysis of Vistusertib Plus Paclitaxel Regimen217
Errors in Key Points and Abstract214
Error in Text202
Piercing the Fog190
Immunotherapy in Prepatients—Preventing or Promoting a Malignant Transformation?184
Association of Body Mass Index With the Safety Profile of Nivolumab With or Without Ipilimumab184
Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia175
The Multidisciplinary Cancer Conference167
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab159
High-risk Medulloblastoma—Balancing the High Stakes of Molecular Profiling to Enhance Treatment Responsivity152
Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors151
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults144
Methodology Concerns Regarding Claims Data Studies in Transgender Health—Reply134
Firearm Safety for Patients Diagnosed With Cancer—A Role in Suicide Prevention132
The Inclusion of Women in Global Oncology Drug Trials Over the Past 20 Years132
Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer125
The Global Economic Cost of Cancer—Estimating It Is Just the First Step!124
The Implications of the Supreme Court Decision to Overturn Roe v Wade for Women With Pregnancy-Associated Cancers123
Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors122
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration122
Established Cancer Predisposition Genes in Single and Multiple Cancer Diagnoses120
Diversity Trends by Sex and Underrepresented in Medicine Status Among US Radiation and Medical Oncology Faculty Over 5 Decades116
Natural Language Processing–Assessed Unmet Medical and Social Needs in Cancer Crowdfunding Stories113
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer113
Long-term Effect of Machine Learning–Triggered Behavioral Nudges on Serious Illness Conversations and End-of-Life Outcomes Among Patients With Cancer113
Use of Participation to Prevalence Ratio for Evaluating the Representation Status of Women in Oncology Clinical Trials—Reply110
The Most Difficult Lesson From Cancer Just Might Be Its Most Valuable109
SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US108
Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography—The IP1-PROSTAGRAM Study—Reply106
Association of 5α-Reductase Inhibitor Use With Prostate Cancer–Specific Mortality—Reply106
What Is the Optimal Treatment for Vulnerable Older Women With Ovarian Cancer?106
Coding Errors in Study of Eligibility for Lung Cancer Screening102
Internal Mammary Nodal Irradiation Debate for Node-Positive Breast Cancer—Has the Needle Moved?—Reply102
Is Colorectal Cancer Screening Absolutely Beneficial for Older Adults?99
Is Appendiceal Cancer a Lynch Syndrome–Associated Cancer?98
Errors in Reported Outcomes and Table97
Results of the TARGET-TP Randomized Clinical Trial94
Variability in COVID-19 Vaccine Response Among People With Cancer92
The SOUND Randomized Clinical Trial Results92
Trauma91
JAMA Oncology88
An Atypical Rash on the Chest88
Immunotherapy Before Chemoradiotherapy—More Is Better?87
The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval85
Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer85
Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation84
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis84
Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy83
Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China82
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer82
Shifting Toward Precision Oncology in SCLC Treatment82
Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma80
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Don79
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma78
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent78
Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus–Associated Oropharyngeal Cancer77
Unplanned Hospitalization Prediction During Chemoradiotherapy Via Machine Learning Classifiers—Reply77
Steroid Dose and Duration, Immortal Time Bias, and Survival After High-grade Immune-Related Adverse Events—Reply76
Clinical Trial Diversity—Will We Know It When We See It?75
Error in Text75
Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs?74
Accelerated Approval Is Not Conditional Approval74
Disparities in Trends of Gastroenteropancreatic Neuroendocrine Tumor Incidence74
0.21311616897583